27 October 2016 EMA/719243/2016 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: influenza vaccine (split virion, inactivated, prepared in cell cultures)

Procedure no.: PSUSA/00010299/201603

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged.

Product Name (in

MRP/DCP

authorisation country)

Authorisation

National Authorisation Number

MAH of product in the

Member State where

member state

product is authorised

number

45349

NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O. NANOTHERAPEUTICS BOHUMIL, S.R.O.

29303

NANOTHERAPEUTICS BOHUMIL, S.R.O.

FI

PL 00116/0654

NANOTHERAPEUTICS BOHUMIL, S.R.O.

UK

Preflucel

AT/H/0253/001

2-00373

Preflucel

AT/H/0253/001

Not available

Preflucel

AT/H/0253/001

59/772/10-C

Preflucel

AT/H/0253/001

PEI.H.11496.01.1

Preflucel

AT/H/0253/001

47867

Preflucel

AT/H/0253/001

TBA

Preflucel

AT/H/0253/001

PA2077/001/001

Preflucel

AT/H/0253/001

Not available

Preflucel

AT/H/0253/001

10-8003

Preflucel

AT/H/0253/001

18259

Preflucel

AT/H/0253/001

5380415, 5380407

Preflucel AT/H/0253/001 Preflucel injektioneste, suspensio, esitäytetyssä ruiskussa Influenssarokote (soluissa tuotettu inaktivoitu osavirusrokote) AT/H/0253/001 PREFLUCEL Suspension for injection in a pre-filled syringe Influenza Vaccine (split virion, inactivated, prepared in cell cultures) AT/H/0253/001/1A/11

List of nationally authorised medicinal products EMA/719243/2016

AT BE CZ DE DK ES IE NL NO PL PT SE

Page 2/2

influenza vaccine (split virion, inactivated, prepared in cell cultures)

Oct 27, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... PL 00116/0654. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. UK.

73KB Sizes 0 Downloads 171 Views

Recommend Documents

Influenza vaccine (split virion, inactivated, prepared in cell cultures)
Oct 27, 2016 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

Active substance: influenza vaccine (surface antigen, inactivated ...
Apr 14, 2016 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our website www.ema.europa.eu/contact. © European ...

Active substance: influenza vaccine (surface antigen, inactivated ...
Apr 14, 2016 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of ... Procedure Management and Committees Support.

Influenza Vaccine Information.pdf
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. Influenza Vaccine Information.pdf. Influenza Vaccine Information.pdf. Open. Extract. Open with. Sign In. Mai

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

Vaccine Information - Influenza (Flu).pdf
Sign in. Loading… Whoops! There was a problem loading more pages. Retrying... Whoops! There was a problem previewing this document. Retrying.

Influenza Vaccine Clinic letter-Form.pdf
Influenza Vaccine Clinic letter-Form.pdf. Influenza Vaccine Clinic letter-Form.pdf. Open. Extract. Open with. Sign In. Main menu.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Afluria Suspension injectable dans une seringue préremplie. accin contre l'influenza. (virion fragmenté, inactivé). DE/H/1938/001. 1716/06040039. SEQIRUS GMBH. LU. Afluria Suspensión inyectable en jeringa precargada Vacuna antigrip

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Chiromas, suspensión inyectable en jeringa precargada Vacuna antigripal de antígeno de superficie, inactivado, con adyuvante MF59C.1.1. IT/H/0104/001. 63.566. SEQIRUS S.R.L.. ES. Fluad. Injektionssuspension in einer Fertigspritze. In

Anaphylaxis from the Influenza Virus Vaccine
14 Dec 2007 - enza vaccine and gelatin were positive and egg (white, whole, and yolk) was negative. Immunocap serum-specific. IgE testing to egg (white, whole, and yolk) and gelatin were negative ( ! 0.35 kU/l). IgE immunoblots were performed with 2

Can we measure influenza vaccine effectiveness using ...
Spanish Influenza Sentinel Surveillance System, 2008-9. Instituto. De Salud. Carlos III. C. Savulescu, S. de Mateo, M. Valenciano,. A. Larrauri, and cycEVA study ...

Effectiveness of the 2003–2004 influenza vaccine ...
This research has been conducted in compliance with all applicable fed- eral regulations governing the protection of human subjects in research under.

Influenza Vaccine Effectiveness Among Children 6 to ...
96 (39.2). 4444 (48.2). 84 (49.7). 622 (49.0). Insurance .001 .51. Private. 62 (25.3). 5860 (63.5). 65 (38.5). 455 (35.9). Public/noneb. 183 (74.7). 3363 (36.5).

Information Elicitation and Influenza Vaccine Production
eters consistent with the influenza vaccine supply chain? ...... chain. Unless otherwise specified below, graphs and data assume c = $6, L = $8, δ = 0.4, pa = $40, ...

Influenza Vaccine Effectiveness Among Children 6 to ...
... MS; Ardythe Morrow, PhD; Mekibib Altaye, PhD; Yuwei Zhu, MD, MS; Sandra Ambrose, MBA; ... venting influenza-related health care visits among chil- ...... of-care influenza testing on management of febrile children [published online No-.

Functional Split between Parietal and Entorhinal Cortices ... - Cell Press
Feb 22, 2012 - perform a ''virtual hairpin'' task in which the animals ran stereo- ..... Spike sorting was performed offline using graphical cluster-cutting software.

Global Dendritic Cell Cancer Vaccine Industry 2015.pdf
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. Global Dendritic ...

Influenza in Dogs and Cats
a Los Angeles County Department of Public Health, Veterinary Public Health ..... H5N1.31 Animal shelters in Germany reported a surge of phone calls and an ...

Split alignment
Apr 13, 2012 - I use the standard affine-gap scoring scheme, with one additional parameter: a .... Ai,j: the alignment score for query base j in alignment i.

MADRAS HC DELIVERS SPLIT VERDICT IN CHALLENGE ...
Mr.P.Wilson, Senior Counsel. for M/s.P.Wilson Associates for R-4. Mr.R.Vijay Narayan, Senior Counsel,. for M/s.Joseph George Mayiladumpura. (Intervenor in WMP No.2779 of 2017). Mr.Krishna Srinivasan. for M/s.S.Ramasubramanian Associates. (Intervenor

Polymeric latexes prepared in the presence of 2-acrylamido-2 ...
Feb 6, 2001 - recovery of natural resources in the mining, petroleum and ..... ization of the acid monomer With an alkaline agent such as a ..... This data,.

Vaccine Providers.pdf
accepted insurance. Page 1 of 1. Vaccine Providers.pdf. Vaccine Providers.pdf. Open. Extract. Open with. Sign In. Main menu. Displaying Vaccine Providers.pdf.

Immune control of an SIV challenge by a T-cell-based vaccine ... - Nature
Nov 9, 2008 - Consistent with these results, preclinical studies have demonstrated that rAd5 vectors expressing simian immunodefi- ciency virus (SIV) Gag ...

DNA barcoding for species Identification in prepared ...
associations are focusing on food safety and quality. Species identification is a major concern due to the increased awareness among consumers regarding the composition of foods and the need to verify labeling statements. The increasing demand for fi